The world’s global marijuana market is soon hitting the billion marks in the stock exchange. As Canadian authorities pointing to the legislation of marijuana, there is a reality in increasing the Canadian marijuana stocks.
As the clock ticks towards the legalization of the outdoor pot, growers are waiting for a positive sign to get access to the outdoor cannabis cultivation. The liberal government of Canada is opening up ways for the future in the hope of boosting Canadian stocks. Some prefer to call it the pot stock.
In this article, a sample of some of the top and probably the best Canadian marijuana stocks as shown below;
Curaleaf Holdings INC
The company is part of an integration of the multi-state cannabis operator (MSO) in the USA. Right now, the company is in its rapid growth development phase. The primary focus has always been trust, reliability, and quality. With branches more than 12 states and 42 dispensaries, 11 processing sites, and 12 cultivation sites.
Curaleaf does not need orientation on significant matters like medical marijuana, the markets, and the CBD, including the hemp sector. Its most considerable footprint yet is in branded retail stores with an average of almost three visitors.
In March 2018, the company’s first quarter and fiscal year results reported US$87.8 million. They had a projection of $400 million for the following year. They recently opened its doors to the 23rd and the only Florida dispensary.
The market capitalization stands at $6.47 Billion
MediPharm Labs Corporation
MediPharm is the first company in Canada under the ACMK without obtaining the cultivation license. They produce pure cannabis oils that are to the standards of pharmaceuticals. They are ISO certified for a clean environment and working laboratories.
Now the company has a 150,000 kg manufacturing capacity and plan to extend this favor to about 250,000 kilograms by the second quarter. Their investment is seen state of the art technology, experts, and extraction methods that help in the delivery of safe and precise-dosages.
MediPharm Australia, a subsidiary of MediPharm Corporation, had its application to extract and deliver the exact recommended dosage of cannabis. MediPharm Corporation, on its financial results in April 2013, reported a figure of $10.2 Million profits and a gross profit of $4 million.
The market capitalization stands at $627.1 Million
Charlotte Web Holdings, Inc.
Canadian marijuana stocks continue to grow as this company continues standing on its leading path as a producer and distributor of hemp-derived cannabidiol for wellness and health. The company works on quality products using the hemp genetics made from the CBD extracts. Charlotte Web Holdings products are CBD capsules, CBD oil tinctures, CBD pet products.
More than 4,000 retail locations that produce 675,000 lbs. of hemp. The company now has manufacturing and a research and development facility hoping to expand in the future. In 2018, the firm cultivated more than 300 acres of hemp inside facilities that specialize in CO2 and alcohol extraction.
The firm’s financial results for the first quarter of 2018 stated a full year income of US$69.5 million.
The market capitalization stands at $2.3 Billion
Cronos Group Inc.
This company is vertically inclined and a Canadian marijuana stocks company with diversification and global presence. The investments of the company are inclined towards the licensing of their production and selling of marijuana. All its subsidiaries are licensed to produce, sell, and cultivate medical marijuana and cannabis oil.
The current capacity is 355,500 square feet, which produces 40, 150 kilograms. In March 2018, the groups’ financial year resulted in revenues at $5.6 Million, showing a 24% increment.
The market capitalization stands at $7.4 Billion
FSD Pharma
The company is licensed to use hydroponic production to cultivate and process cannabis. Based in Ontario, Canada, with a potential of about 3.8 million sq. production units, that could as well be the world’s largest.
FSD aims to work with companies that have enough exposure and experience with cannabis products. With a solid balance sheet, the company can meet some of its obligations when making strategic movements.
In February, the company announced a new five-year loan and supply agreement with Canntab Therapeutics Ltd and World Class Extractions Inc.
The market capitalization stands at $347 Million
NextLeaf Solutions Limited
This company specializes in Canadian extraction technology that has helped it to develop some patents based on its unique industrial-scale production. The company’s future expectation is the project with a processing ability of 100,000 kg of dry cannabis biomass
As far as reports go, NextLeaf Solutions is the only company whose shares are trading publicly.
The market capitalization stands at $53.1 Million.
